Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | CASP6 | P55212 | 2/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.50 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | S100A4 | P26447 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30012694 | 1.00 | TDP1 (0.55) | TDP1ALDH1A1PARP1CASP6DUSP3 | |
| SCHEMBL1610805 | 0.81 | CASP6 (0.47) | TDP1ALDH1A1PARP1CASP6GPR35 | |
| SCHEMBL3477342 | 0.81 | PARP1 (0.60) | TDP1ALDH1A1PARP1CASP6GPR35 | |
| SCHEMBL28027350 | 0.78 | TDP1 (0.73) | TDP1ALDH1A1PARP1GPR35MAPT | |
| SCHEMBL11568200 | 0.76 | GRIN2D (0.56) | TDP1ALDH1A1PARP1PTPN11MAPT | |
| SCHEMBL29765205 | 0.74 | TDP1 (0.67) | TDP1ALDH1A1PARP1GPR35MAPT | |
| SCHEMBL10526689 | 0.74 | TDP1 (0.74) | TDP1ALDH1A1PARP1GPR35MAPT | |
| SCHEMBL1684003 | 0.74 | TDP1 (0.67) | TDP1ALDH1A1PARP1GPR35MAPT | |
| SCHEMBL4065593 | 0.74 | ALDH1A1 (0.54) | TDP1ALDH1A1PARP1MAPTMAPK1 | |
| SCHEMBL8927887 | 0.73 | TDP1 (0.59) | TDP1ALDH1A1PARP1CASP6GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4073266-B1 | METHOD FOR CARRYING OUT AN AMPLIFICATION REACTION IN A MICROFLUIDIC APPARATUS | BOSCH GMBH ROBERT (DE) | 2026-05-27 | — | — | EP | claimed |
| US-20230002810-A1 | Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus | ROBERT BOSCH GMBH (DE) | 2023-01-05 | — | — | US | claimed |
| EP-4073266-A1 | METHOD FOR CARRYING OUT AN AMPLIFICATION REACTION IN A MICROFLUIDIC APPARATUS | Robert Bosch GmbH (DE) | 2022-10-19 | — | — | EP | claimed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| WO-2021116322-A1 | METHOD FOR CARRYING OUT AN AMPLIFICATION REACTION IN A MICROFLUIDIC APPARATUS | ROBERT BOSCH GMBH (DE) | 2021-06-17 | — | — | WO | claimed |
| US-20210005900-A1 | METHOD OF GENERATING ENERGY FROM A HYDRAZIDE CONTAINING ANODE FUEL, AND FUEL CELL | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-01-07 | — | — | US | claimed |
| US-9732043-B2 | Process for preparing 5-amino-2,3-dihydrophthalazine-1,4-dione monosodium salt | BACH PHARMA, INC. (US) | 2017-08-15 | — | — | US | claimed |
| EP-2393361-B1 | PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BACH PHARMA INC (US) | 2016-12-07 | — | — | EP | claimed |
| EP-2389364-B1 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP Z O O (PL) | 2016-10-26 | — | — | EP | claimed |
| US-20160237039-A1 | PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Occhiuti & Rohlicek LLP | 2016-08-18 | — | — | US | claimed |
| EP-2389364-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma Pl SP. Z.O.O (PL) | 2011-11-30 | — | — | EP | claimed |
| US-20110275642-A1 | NEW METHOD FOR OBTAINING 5-AMINO 2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma PL SP. Z.O.O. (PL) | 2011-11-10 | — | — | US | claimed |
| US-8039605-B2 | Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2011-10-18 | — | — | US | claimed |
| US-20100222584-A1 | PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BACH PHARMA, INC. (US) | 2010-09-02 | — | — | US | claimed |
| WO-2010091257-A1 | PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BACH PHARMA, INC. (US) | 2010-08-12 | — | — | WO | claimed |
| WO-2010082858-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP. Z.O.O (PL) | 2010-07-22 | — | — | WO | claimed |
| EP-1203587-B1 | A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF | ABIDOV MUSA TAZHUDINOVICH (RU) | 2010-07-14 | — | — | EP | claimed |
| US-20020198208-A1 | MEDICINAL PREPARATION AND PROCESS FOR MANUFACTURING THEREOF | ABIDOV, MUSA TAZHUDINOVICH (RU) | 2002-12-26 | — | — | US | claimed |
| EP-1203587-A1 | A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF | Abidov, Musea Tazhudinovich (RU) | 2002-05-08 | — | — | EP | claimed |
| US-4207112-A | STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1980-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275642-A1 | NEW METHOD FOR OBTAINING 5-AMINO 2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ADH1C, SCN5A, ADH1A | TDP1 1418/4885ALDH1A1 91/4885PARP1 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.